Detail Information of Epigenetic Regulations

General Information of Drug Transporter (DT)
DT ID DTD0047 Transporter Info
Gene Name ABCA9
Transporter Name ATP-binding cassette sub-family A member 9
Gene ID
10350
UniProt ID
Q8IUA7
Epigenetic Regulations of This DT (EGR)

Methylation

  Breast cancer

            5 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

 Methylation of ABCA9 in breast cancer [ 1 ]

Location

 5'UTR (cg19464780)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: 1.24E+00 Statistic Test p-value: 3.50E-04; Z-score: 1.80E+00

Methylation in Case

 6.46E-01 (Median) Methylation in Control 5.22E-01 (Median)

Studied Phenotype

 Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 2

 Methylation of ABCA9 in breast cancer [ 1 ]

Location

 TSS1500 (cg01517431)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: -1.12E+00 Statistic Test p-value: 8.03E-04; Z-score: -9.81E-01

Methylation in Case

 4.88E-01 (Median) Methylation in Control 5.49E-01 (Median)

Studied Phenotype

 Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 3

 Methylation of ABCA9 in breast cancer [ 1 ]

Location

 TSS200 (cg22093121)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: 1.79E+00 Statistic Test p-value: 4.26E-10; Z-score: 2.01E+00

Methylation in Case

 1.94E-01 (Median) Methylation in Control 1.08E-01 (Median)

Studied Phenotype

 Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 4

 Methylation of ABCA9 in breast cancer [ 1 ]

Location

 Body (cg26352073)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: -1.08E+00 Statistic Test p-value: 2.52E-03; Z-score: -8.58E-01

Methylation in Case

 8.41E-01 (Median) Methylation in Control 9.08E-01 (Median)

Studied Phenotype

 Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 5

 Methylation of ABCA9 in breast cancer [ 1 ]

Location

 3'UTR (cg12504828)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: -1.46E+00 Statistic Test p-value: 1.58E-06; Z-score: -1.58E+00

Methylation in Case

 5.04E-01 (Median) Methylation in Control 7.38E-01 (Median)

Studied Phenotype

 Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

 Patient tissue samples

  Colorectal cancer

            4 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

 Methylation of ABCA9 in colorectal cancer [ 2 ]

Location

 5'UTR (cg19464780)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: -1.01E+00 Statistic Test p-value: 1.90E-02; Z-score: -6.36E-01

Methylation in Case

 9.15E-01 (Median) Methylation in Control 9.29E-01 (Median)

Studied Phenotype

 Colorectal cancer [ ICD-11: 2B91]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 2

 Methylation of ABCA9 in colorectal cancer [ 2 ]

Location

 TSS1500 (cg06213598)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: -1.06E+00 Statistic Test p-value: 3.71E-06; Z-score: -1.82E+00

Methylation in Case

 8.57E-01 (Median) Methylation in Control 9.09E-01 (Median)

Studied Phenotype

 Colorectal cancer [ ICD-11: 2B91]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 3

 Methylation of ABCA9 in colorectal cancer [ 2 ]

Location

 TSS1500 (cg01517431)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: -1.06E+00 Statistic Test p-value: 8.31E-05; Z-score: -1.32E+00

Methylation in Case

 8.10E-01 (Median) Methylation in Control 8.60E-01 (Median)

Studied Phenotype

 Colorectal cancer [ ICD-11: 2B91]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 4

 Methylation of ABCA9 in colorectal cancer [ 2 ]

Location

 3'UTR (cg12504828)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: -1.03E+00 Statistic Test p-value: 1.10E-03; Z-score: -8.50E-01

Methylation in Case

 8.04E-01 (Median) Methylation in Control 8.24E-01 (Median)

Studied Phenotype

 Colorectal cancer [ ICD-11: 2B91]

Experimental Material

 Patient tissue samples

  Panic disorder

            2 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

 Methylation of ABCA9 in panic disorder [ 3 ]

Location

 5'UTR (cg19464780)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: -1.08E+00 Statistic Test p-value: 1.67E-03; Z-score: -2.54E-01

Methylation in Case

 1.36E+00 (Median) Methylation in Control 1.47E+00 (Median)

Studied Phenotype

 Panic disorder [ ICD-11: 6B01]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 2

 Methylation of ABCA9 in panic disorder [ 3 ]

Location

 TSS1500 (cg01517431)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: -1.21E+00 Statistic Test p-value: 3.79E-03; Z-score: -4.03E-01

Methylation in Case

 8.20E-01 (Median) Methylation in Control 9.93E-01 (Median)

Studied Phenotype

 Panic disorder [ ICD-11: 6B01]

Experimental Material

 Patient tissue samples

  Hepatocellular carcinoma

            2 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

 Methylation of ABCA9 in hepatocellular carcinoma [ 4 ]

Location

 TSS1500 (cg06213598)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: -1.22E+00 Statistic Test p-value: 4.79E-09; Z-score: -2.20E+00

Methylation in Case

 6.22E-01 (Median) Methylation in Control 7.60E-01 (Median)

Studied Phenotype

 Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 2

 Methylation of ABCA9 in hepatocellular carcinoma [ 4 ]

Location

 3'UTR (cg00630480)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: -1.18E+00 Statistic Test p-value: 2.19E-12; Z-score: -2.20E+00

Methylation in Case

 6.35E-01 (Median) Methylation in Control 7.50E-01 (Median)

Studied Phenotype

 Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

 Patient tissue samples

  Lung adenocarcinoma

            1 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

 Methylation of ABCA9 in lung adenocarcinoma [ 5 ]

Location

 TSS1500 (cg01517431)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: -1.10E+00 Statistic Test p-value: 2.42E-02; Z-score: -2.30E+00

Methylation in Case

 6.83E-01 (Median) Methylation in Control 7.54E-01 (Median)

Studied Phenotype

 Lung adenocarcinoma [ ICD-11: 2C25.0]

Experimental Material

 Patient tissue samples

  Pancretic ductal adenocarcinoma

            4 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

 Methylation of ABCA9 in pancretic ductal adenocarcinoma [ 6 ]

Location

 TSS1500 (cg19896639)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: -1.39E+00 Statistic Test p-value: 2.99E-04; Z-score: -4.89E-01

Methylation in Case

 6.90E-02 (Median) Methylation in Control 9.61E-02 (Median)

Studied Phenotype

 Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 2

 Methylation of ABCA9 in pancretic ductal adenocarcinoma [ 6 ]

Location

 TSS200 (cg10534439)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: -1.28E+00 Statistic Test p-value: 4.30E-05; Z-score: -9.65E-01

Methylation in Case

 1.18E-01 (Median) Methylation in Control 1.51E-01 (Median)

Studied Phenotype

 Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 3

 Methylation of ABCA9 in pancretic ductal adenocarcinoma [ 6 ]

Location

 Body (cg03851835)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: -3.42E+00 Statistic Test p-value: 4.85E-13; Z-score: -2.18E+00

Methylation in Case

 1.56E-01 (Median) Methylation in Control 5.34E-01 (Median)

Studied Phenotype

 Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 4

 Methylation of ABCA9 in pancretic ductal adenocarcinoma [ 6 ]

Location

 Body (cg06845079)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: -1.01E+00 Statistic Test p-value: 9.20E-06; Z-score: -1.09E+00

Methylation in Case

 9.14E-01 (Median) Methylation in Control 9.25E-01 (Median)

Studied Phenotype

 Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0]

Experimental Material

 Patient tissue samples

  Papillary thyroid cancer

            3 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

 Methylation of ABCA9 in papillary thyroid cancer [ 7 ]

Location

 TSS1500 (cg06213598)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: 1.03E+00 Statistic Test p-value: 1.22E-03; Z-score: 7.56E-01

Methylation in Case

 9.03E-01 (Median) Methylation in Control 8.81E-01 (Median)

Studied Phenotype

 Papillary thyroid cancer [ ICD-11: 2D10.1]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 2

 Methylation of ABCA9 in papillary thyroid cancer [ 7 ]

Location

 TSS200 (cg22093121)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: 1.97E+00 Statistic Test p-value: 9.31E-18; Z-score: 2.66E+00

Methylation in Case

 2.35E-01 (Median) Methylation in Control 1.19E-01 (Median)

Studied Phenotype

 Papillary thyroid cancer [ ICD-11: 2D10.1]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 3

 Methylation of ABCA9 in papillary thyroid cancer [ 7 ]

Location

 3'UTR (cg12504828)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: -1.02E+00 Statistic Test p-value: 6.06E-03; Z-score: -5.18E-01

Methylation in Case

 7.16E-01 (Median) Methylation in Control 7.32E-01 (Median)

Studied Phenotype

 Papillary thyroid cancer [ ICD-11: 2D10.1]

Experimental Material

 Patient tissue samples

  Bladder cancer

            2 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

 Methylation of ABCA9 in bladder cancer [ 8 ]

Location

 TSS200 (cg22093121)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: 3.29E+00 Statistic Test p-value: 6.56E-09; Z-score: 8.66E+00

Methylation in Case

 3.71E-01 (Median) Methylation in Control 1.13E-01 (Median)

Studied Phenotype

 Bladder cancer [ ICD-11: 2C94]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 2

 Methylation of ABCA9 in bladder cancer [ 8 ]

Location

 Body (cg26352073)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: -1.10E+00 Statistic Test p-value: 2.52E-07; Z-score: -7.10E+00

Methylation in Case

 8.30E-01 (Median) Methylation in Control 9.11E-01 (Median)

Studied Phenotype

 Bladder cancer [ ICD-11: 2C94]

Experimental Material

 Patient tissue samples

  Prostate cancer

            1 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

 Methylation of ABCA9 in prostate cancer [ 9 ]

Location

 Body (cg26829418)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: -1.61E+00 Statistic Test p-value: 2.71E-02; Z-score: -4.51E+00

Methylation in Case

 5.03E-01 (Median) Methylation in Control 8.09E-01 (Median)

Studied Phenotype

 Prostate cancer [ ICD-11: 2C82]

Experimental Material

 Patient tissue samples
References
1 Genome-wide Scan for Methylation Profiles in Breast Cancer
2 Differences in DNA methylation signatures reveal multiple pathways of progression from adenoma to colorectal cancer. Gastroenterology. 2014 Aug;147(2):418-29.e8.
3 DNA Methylation signatures in panic disorder. Transl Psychiatry. 2017 Dec 18;7(12):1287.
4 Exploring genome-wide DNA methylation profiles altered in hepatocellular carcinoma using Infinium HumanMethylation 450 BeadChips. Epigenetics. 2013 Jan;8(1):34-43.
5 DNA methylation analysis of lung adenocarcinoma and adjacent non-tumor tissues
6 Genome-wide DNA methylation patterns in pancreatic ductal adenocarcinoma reveal epigenetic deregulation of SLIT-ROBO, ITGA2 and MET signaling. Int J Cancer. 2014 Sep 1;135(5):1110-8.
7 Prognostic Classifier Based on Genome-Wide DNA Methylation Profiling in Well-Differentiated Thyroid Tumors. J Clin Endocrinol Metab. 2017 Nov 1;102(11):4089-4099.
8 DNA Methylation Dynamics in Urological Tumors.
9 Reducing the risk of false discovery enabling identification of biologically significant genome-wide methylation status using the HumanMethylation450 array. BMC Genomics. 2014 Jan 22;15:51.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.